{
    "title": "AstraZeneca shares surge as pharma giant's Covid-19 antibody treatment Evusheld gets green light from European Union regulators",
    "url": "https://www.dailymail.co.uk/money/markets/article-11218959/AstraZeneca-shares-surge-EU-regulator-backs-Covid-drug.html",
    "date": "2022-09-16",
    "keywords": [
        "treatment",
        "drug",
        "prevention",
        "evusheld",
        "year",
        "ema",
        "share",
        "fund",
        "today",
        "covid19",
        "market",
        "covid",
        "europe",
        "japan",
        "country",
        "virus",
        "risk",
        "astrazeneca",
        "commission",
        "trade",
        "month",
        "respiratory",
        "investment",
        "account",
        "fee",
        "antibody",
        "light",
        "ftse",
        "giant",
        "medicines",
        "agency",
        "use",
        "virusearlier",
        "majority",
        "purpose",
        "cure",
        "c19it",
        "virusfighting",
        "protection",
        "covidhowever",
        "oxygen",
        "business",
        "pound",
        "astra",
        "approval",
        "cancer",
        "imfinzi",
        "firm",
        "shot",
        "arm",
        "article",
        "decision",
        "cent",
        "morning",
        "friday",
        "world",
        "az",
        "group",
        "vaccinethe",
        "december",
        "half",
        "partner",
        "diseasesthe",
        "regulator",
        "beyfortus",
        "rsvrsv",
        "diy",
        "capital",
        "isa",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}